Insmed (INSM)
126.29
-0.39 (0.31%)
Upcoming Events
Latest Headlines
Insmed to Present at September 2026 Investor Conferences
August 26, 2026 7:00 AM - PR NewsWire
Form 4 INSMED Inc For: Aug 17 Filed by: SHAROKY MELVIN MD
August 25, 2026 7:03 PM - SEC Filing
Insmed (INSM) PT Raised to $195 at Mizuho
August 24, 2026 3:37 PM - StreetInsider
Japan approves Insmed's Brinsupri for lung disease treatment
August 24, 2026 7:03 AM - StreetInsider
BRINSUPRI® (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
August 24, 2026 7:00 AM - PR NewsWire
Form 4 INSMED Inc For: Aug 17 Filed by: SHAROKY MELVIN MD
August 19, 2026 4:10 PM - SEC Filing
Form 144 INSMED Inc Filed by: SHAROKY MELVIN MD
August 17, 2026 4:18 PM - SEC Filing
Form SCHEDULE 13G/A INSMED Inc Filed by: Darwin Global Management, Ltd.
August 14, 2026 5:04 PM - SEC Filing
Form 4 INSMED Inc For: Aug 10 Filed by: Adsett Roger
August 12, 2026 5:05 PM - SEC Filing
Form 144 INSMED Inc Filed by: Adsett Roger
August 10, 2026 5:43 PM - SEC Filing
Insmed (INSM) PT Lowered to $175 at JPMorgan
August 10, 2026 8:56 AM - StreetInsider
Insmed (INSM) PT Raised to $195 at Truist Securities
August 10, 2026 7:22 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Insmed (INSM)
August 10, 2026 6:40 AM - StreetInsider
Form 4 INSMED Inc For: Aug 06 Filed by: Flammer Martina M.D.
August 7, 2026 4:39 PM - SEC Filing
Insmed (INSM) PT Raised to $169 at Wells Fargo
August 7, 2026 8:20 AM - StreetInsider
Form 144 INSMED Inc Filed by: Flammer Martina M.D.
August 6, 2026 4:12 PM - SEC Filing
Form SCHEDULE 13G/A INSMED Inc Filed by: FMR LLC
August 6, 2026 10:31 AM - SEC Filing
Insmed (INSM) Tops Q2 EPS by 62c; offers guidance
August 6, 2026 7:16 AM - StreetInsider
Form 8-K INSMED Inc For: Aug 06
August 6, 2026 7:01 AM - SEC Filing
Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update
August 6, 2026 7:01 AM - PR NewsWire
Form 10-Q INSMED Inc For: Jun 30
August 6, 2026 7:00 AM - SEC Filing
Cantor Fitzgerald Reiterates Overweight Rating on Insmed (INSM) Ahead of Q2 Results
July 28, 2026 9:44 AM - StreetInsider
Form 4 INSMED Inc For: Jul 23 Filed by: Lewis William
July 24, 2026 5:02 PM - SEC Filing
Form 144 INSMED Inc Filed by: Lewis William
July 23, 2026 4:39 PM - SEC Filing
Insmed to Host Second-Quarter 2026 Financial Results Conference Call on Thursday, August 6, 2026
July 23, 2026 7:00 AM - PR NewsWire
Form SCHEDULE 13G/A INSMED Inc Filed by: JPMORGAN CHASE & CO
July 22, 2026 1:39 PM - SEC Filing
Raymond James sees potential for beats across biopharma coverage
July 21, 2026 6:12 AM - StreetInsider
BMO Capital Starts Insmed (INSM) at Outperform
July 20, 2026 4:36 PM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Insmed (INSM)
July 20, 2026 6:44 AM - StreetInsider
Insmed (INSM) Reiterated at Buy by Stifel After TPIP P2b Trial Data
July 17, 2026 7:20 AM - StreetInsider
Insmed reports 12-month OLE data for TPIP in PAH patients
July 16, 2026 7:02 AM - StreetInsider
Form 8-K INSMED Inc For: Jul 16
July 16, 2026 7:01 AM - SEC Filing
Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Patients with Pulmonary Arterial Hypertension
July 16, 2026 7:00 AM - PR NewsWire
Insmed (INSM) PT Raised to $161 at Wells Fargo
July 15, 2026 6:52 AM - StreetInsider
Form 4 INSMED Inc For: Jul 09 Filed by: Lewis William
July 10, 2026 4:03 PM - SEC Filing
Form 144 INSMED Inc Filed by: Lewis William
July 9, 2026 4:30 PM - SEC Filing
Form 4 INSMED Inc For: Jul 06 Filed by: Flammer Martina M.D.
July 8, 2026 4:03 PM - SEC Filing
Form 144 INSMED Inc Filed by: Flammer Martina M.D.
July 6, 2026 4:20 PM - SEC Filing
Palvella Therapeutics adds Matt Pauls to its board of directors
June 30, 2026 7:30 AM - StreetInsider
Form 4 INSMED Inc For: Jun 25 Filed by: Lewis William
June 26, 2026 4:04 PM - SEC Filing
Form 144 INSMED Inc Filed by: Lewis William
June 25, 2026 4:14 PM - SEC Filing
Form 4 INSMED Inc For: Jun 23 Filed by: Butera Samuele
June 24, 2026 4:16 PM - SEC Filing
Form 3 INSMED Inc For: Jun 23 Filed by: Butera Samuele
June 24, 2026 4:13 PM - SEC Filing
Form 4 INSMED Inc For: Jun 22 Filed by: Smith Michael Alexander
June 24, 2026 4:12 PM - SEC Filing
Insmed names Samuele Butera to lead global respiratory unit
June 23, 2026 7:00 AM - StreetInsider
Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory
June 23, 2026 7:00 AM - PR NewsWire
Form 144 INSMED Inc Filed by: Smith Michael Alexander
June 22, 2026 4:21 PM - SEC Filing
Insmed (INSM) PT Lowered to $160 at Evercore ISI
June 22, 2026 7:43 AM - StreetInsider
Recent weakness provides an opportunity to buy this stock
June 16, 2026 12:00 PM - StreetInsider
Insmed (INSM) PT Lowered to $192 at Mizuho
June 16, 2026 6:40 AM - StreetInsider
NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
June 11, 2026 8:16 PM - StreetInsider
Nasdaq-100 Index® June 2026 Quarterly Changes
June 11, 2026 8:00 PM - StreetInsider
Form 4 INSMED Inc For: Jun 08 Filed by: Lewis William
June 10, 2026 4:06 PM - SEC Filing
Insmed (INSM) Reiterated at Overweight by Cantor Fitzgerald
June 10, 2026 7:02 AM - StreetInsider
Form 144 INSMED Inc Filed by: Lewis William
June 8, 2026 4:34 PM - SEC Filing
Full Article List
